Clindamycin, Benzoyl Peroxide

FDA Drug Profile — clindamycin phosphate and benzoyl peroxide

Clindamycin, Benzoyl Peroxide is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including clindamycin phosphate and benzoyl peroxide. Available dosage form: gel.

Drug details

Generic Name
Clindamycin, Benzoyl Peroxide
Brand Names
clindamycin phosphate and benzoyl peroxide
Application Number
ANDA090979
Sponsor
Padagis Israel Pharmaceuticals Ltd
NDC Codes
1
Dosage Forms
GEL
Routes
TOPICAL
Active Ingredients
CLINDAMYCIN PHOSPHATE, BENZOYL PEROXIDE

Indications and Usage

1 INDICATIONS AND USAGE Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% is a combination of clindamycin phosphate (a lincosamide antibacterial) and benzoyl peroxide indicated for the topical treatment of inflammatory acne vulgaris. ( 1.1 ) Limitation of Use: Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% has not been demonstrated to have any additional benefit when compared with benzoyl peroxide alone in the same vehicle when used for the treatment of non-inflammatory acne. ( 1.2 ) 1.1 Indication Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% is indicated for the topical treatment of inflammatory acne vulgaris in patients 12 years and older. 1.2 Limitations of Use Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% has not been demonstrated to have any additional benefit when compared with benzoyl peroxide alone in the same vehicle when used for the treatment of non-inflammatory acne.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.